SAMANTHA BUSH: Open Payments
NPI 1538631254 · GRINDSTONE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 118 payments from 11 companies in 2025. Trend: 2023 $1,703 · 2024 $1,939 · 2025 $1,701
Food & beverage: $1,701
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 62 | $837 |
| Neurocrine BioSciences, Inc. | 18 | $238 |
| Otsuka America Pharmaceutical, Inc. | 13 | $195 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $177 |
| Janssen Pharmaceuticals, Inc | 3 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, REXULTI, INVEGA SUSTENNA, Jornay PM, AUSTEDO XR, ARISTADA.
Industry payments across PA — which companies pay providers there.
